Watch Out: Gilead is Not Done Shopping
Investors and analysts, after all, had been speculating, even nagging, on who the company should buy for several years. Source: BioSpace
Investors and analysts, after all, had been speculating, even nagging, on who the company should buy for several years. Source: BioSpace
Bloomberg said Nestle had submitted the highest offer and Merck was likely to select a winner during the first quarter, but might also choose not to sell the assets after…
Moderna unleashed a torrent of updates yesterday. Source: BioSpace
Valeant's CEO projects that a $1 billion portfolio of key products will help the drug maker fight debt and exclusivity challenges. Source: BioSpace
MabVax’s antibody-based radioimmunotherapy product MVT-1075 is currently being tested on 22 patients with CA19-9 positive malignancies in a Phase I trial. Source: BioSpace
The feud stems from a Florida-based pharmaceutical startup, Altor BioScience, which Cher invested in. Source: BioSpace
Adaptimmune is making strides on becoming a fully integrated cell therapy company behind its T Cell Receptor technology Source: BioSpace
Boragen is located in Research Triangle Park in Durham, N.C., and focuses on boron-based development of anti-bacterials and anti-fungicides for the agricultural industry. Source: BioSpace
GlaxoSmithKline CEO Emma Walmsley is eying a big acquisition to spur revenue growth but is making sure that her company will not overpay. Source: BioSpace
Dr. Erwin Erfe, head of the PAO Forensic Laboratory, said the 4 children they examined contracted dengue 6 months after receiving the vaccine. Source: BioSpace